News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
488,474 Results
Type
Article (8601)
Company Profile (147)
Press Release (479725)
Multimedia
Podcasts (7)
Webinars (8)
Section
Business (167858)
Career Advice (319)
Deals (25904)
Drug Delivery (12)
Drug Development (53636)
Employer Resources (15)
FDA (9883)
Job Trends (8675)
News (240023)
Policy (18044)
Tag
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (504)
Accelerated approval (26)
ADA (19)
Adcomms (6)
Allergies (102)
Alliances (33501)
ALS (106)
Alzheimer's disease (985)
Antibody-drug conjugate (ADC) (282)
Approvals (10479)
Artificial intelligence (327)
ASCO (162)
Autoimmune disease (210)
Automation (28)
Bankruptcy (263)
Best Places to Work (7021)
BIO (37)
Biologics (2)
BIOSECURE Act (5)
Biosimilars (110)
BioSpace Insights (19)
Biotechnology (95)
Bladder cancer (138)
Brain cancer (30)
Breast cancer (512)
Cancer (3705)
Cardiovascular disease (225)
Career advice (254)
Career pathing (1)
CAR-T (185)
CDC (1)
Celiac Disease (1)
Cell therapy (515)
Cervical cancer (34)
Clinical research (48472)
Collaboration (1283)
Commercialization (3)
Compensation (1470)
Complete response letters (37)
COVID-19 (825)
CRISPR (69)
C-suite (780)
Cystic fibrosis (86)
Data (5736)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (349)
Diagnostics (4198)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (159)
Drug pricing (8)
Drug shortages (3)
Duchenne muscular dystrophy (166)
Earnings (73827)
Editorial (4)
Employer branding (2)
Employer resources (15)
Events (88258)
Executive appointments (722)
FDA (12547)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (958)
Gene editing (134)
Generative AI (9)
Gene therapy (348)
GLP-1 (303)
Government (976)
Grass and pollen (2)
Guidances (283)
Healthcare (9438)
Hematology (97)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (109)
Immuno-oncology (56)
Indications (157)
Infectious disease (1015)
Inflammatory bowel disease (133)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (256)
Interviews (43)
IPO (12456)
IRA (2)
Job creations (2005)
Job search strategy (244)
JPM (4)
Kidney cancer (16)
Labor market (5)
Layoffs (75)
Legal (5207)
Licensing (8)
Liver cancer (45)
Longevity (17)
Lung cancer (515)
Lymphoma (255)
Machine learning (27)
Management (4)
Manufacturing (547)
Marketing (9)
MASH (120)
Medical device (8688)
Medtech (8833)
Mergers & acquisitions (14491)
Metabolic disorders (719)
mRNA (62)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (39)
Neuroscience (1850)
NextGen: Class of 2026 (3201)
Non-profit (857)
Now hiring (4)
Obesity (228)
Opinion (13)
Ovarian cancer (161)
Pain (179)
Pancreatic cancer (198)
Parkinson's disease (204)
Partnered (13)
Patents (477)
Patient recruitment (515)
Peanut (31)
People (41675)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15770)
Phase 2 (21698)
Phase 3 (14590)
Pipeline (7412)
Policy (30)
Postmarket research (1580)
Preclinical (6622)
Press Release (34)
Prostate cancer (191)
Psychedelics (8)
Radiopharmaceuticals (189)
Rare diseases (598)
Real estate (3077)
Recruiting (6)
Regulatory (14998)
Reports (23)
Research institute (602)
Resumes & cover letters (48)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (171)
Series B (123)
Service/supplier (5)
Sickle cell disease (64)
Special edition (2)
Spinal muscular atrophy (90)
Sponsored (6)
Startups (2067)
Stomach cancer (3)
Supply chain (51)
Tariffs (2)
The Weekly (3)
Vaccines (340)
Venture capital (20)
Weight loss (75)
Women's health (80)
Date
Today (53)
Last 7 days (214)
Last 30 days (1605)
Last 365 days (19272)
2026 (12488)
2025 (19537)
2024 (23245)
2023 (26841)
2022 (34987)
2021 (37563)
2020 (33753)
2019 (23531)
2018 (17628)
2017 (18939)
2016 (18110)
2015 (24438)
2014 (21799)
2013 (18241)
2012 (20292)
2011 (20547)
2010 (20406)
Location
Africa (237)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (18368)
Australia (2133)
California (12076)
Canada (3185)
China (555)
Colorado (486)
Connecticut (409)
Delaware (212)
Europe (25459)
Florida (1792)
Georgia (381)
Hawaii (3)
Idaho (46)
Illinois (701)
India (51)
Indiana (314)
Iowa (15)
Japan (418)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1222)
Massachusetts (7974)
Michigan (308)
Minnesota (564)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (118)
New Hampshire (60)
New Jersey (2630)
New Mexico (12)
New York (2833)
North Carolina (1283)
North Dakota (4)
Northern California (6042)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2302)
Puerto Rico (20)
Rhode Island (30)
South America (411)
South Carolina (76)
South Dakota (1)
Southern California (5002)
Tennessee (120)
Texas (1967)
United States (39236)
Utah (361)
Vermont (1)
Virginia (154)
Washington D.C. (39)
Washington State (934)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
488,474 Results for "iovance biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - August 21, 2026
August 23, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics to Present at Upcoming Conference
May 21, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - July 17, 2026
July 19, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026
July 30, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
August 6, 2026
·
15 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - June 19, 2026
June 21, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 22, 2026
May 25, 2026
·
3 min read
Press Releases
Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates
May 7, 2026
·
15 min read
Press Releases
Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001
June 1, 2026
·
7 min read
Press Releases
Iovance Biotherapeutics to Present at Upcoming March 2026 Conferences
February 26, 2026
·
3 min read
1 of 48,848
Next
